BRAF and colorectal cancer: Our recent study on colorectal cancers in detailed subsites (from cecum to rectum) has shown that tumor molecular features (including BRAF mutation, MSI and CIMP-high) change along the bowel subsites, and that cecal cancers are associated with KRAS codon 12 and 13 mutations[5,8].